Higher incidence of acute kidney injury in patients treated with piperacillin/tazobactam than in patients treated with cefepime: a single-center retrospective cohort study
Tóm tắt
Từ khóa
Tài liệu tham khảo
Burgess LD, Drew RH. Comparison of the incidence of vancomycin-induced nephrotoxicity in hospitalized patients with and without concomitant piperacillin-tazobactam. Pharmacotherapy. 2014;34(7):670–6.
Gomes DM, Smotherman C, Birch A, Dupree L, Della Vecchia BJ, Kraemer DF, et al. Comparison of acute kidney injury during treatment with vancomycin in combination with piperacillin-tazobactam or cefepime. Pharmacotherapy. 2014;34(7):662–9.
Karino F, Nishimura N, Ishihara N, Moriyama H, Miura K, Hamaguchi S, et al. Nephrotoxicity Induced by Piperacillin – Tazobactam in Late Elderly Japanese Patients with Nursing and Healthcare Associated Pneumonia. Biol Pharm Bull. 2014;37(12):1971–6.
Mac K, Chavada R, Paull S, Howlin K, Wong J. Cefepime induced acute interstitial nephritis - A case report. BMC Nephrol. 2015;16(1):1–6.
Nephrology JS of. Evidence-based Practice Guideline for the Treatment of CKD. Clin Exp Nephrol. 2009;13(6):537–66.
Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, et al. Acute kidney injury network: Report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11(2):1–8.
McCormick H, Tomaka N, Baggett S, Heierman T, LaFosse J, Gilbert S, et al. Comparison of acute renal injury associated with intermittent and extended infusion piperacillin/tazobactam. Am J Health Syst Pharm. American Society of Health-System Pharmacists; 2015 Jun 1;72. (11 Suppl 1):S25–30.
Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2012;48:452–8.
Karino F, Miura K, Fuchita H, Koba N, Nishikawa E, Hotta T, et al. Efficacy and safety of piperacillin/tazobactam versus biapenem in late elderly patients with nursing- and healthcare-associated pneumonia. J Infect Chemother. 2013;19(5):909–15.
Rutter WC, Burgess DR, Talbert JC, Burgess DS. Acute kidney injury in patients treated with vancomycin and piperacillin-tazobactam: A retrospective cohort analysis. J Hosp Med. 2017 Feb 1;12(2):77–82.
Morimoto T, Nagashima H, Morimoto Y, Tokuyama S. Frequency of Acute Kidney Injury Caused by Tazobactam / Piperacillin in Patients with Pneumonia and Chronic Kidney Disease : A Retrospective Observational Study. Yakugaku Zasshi. 2017;137(9):1129–1136.
Navalkele B, Pogue JM, Karino S, Nishan B, Salim M, Solanki S, et al. Risk of acute kidney injury in patients on concomitant vancomycin and piperacillin-tazobactam compared to those on vancomycin and cefepime. Clin Infect Dis. 2017;64(2):116–23.
Jensen J-US, Hein L, Lundgren B, Bestle MH, Mohr T, Andersen MH, et al. Kidney failure related to broad-spectrum antibiotics in critically ill patients: secondary end point results from a 1200 patient randomised trial. BMJ Open. 2012;2(2):e000635.
Van Hal SJ, Paterson DL, Lodise TP. Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter. Antimicrob Agents Chemother. 2013;57(2):734–44.
Erdman MJ, Riha H, Bode L, Chang JJ, Jones GM. Predictors of Acute Kidney Injury in Neurocritical Care Patients Receiving Continuous Hypertonic Saline. Neurohospitalist. 2017;7(1):9–14.
Oliveira JFP, Silva CA, Barbieri CD, Oliveira GM, Zanetta DMT, Burdmann EA. Prevalence and risk factors for aminoglycoside nephrotoxicity in intensive care units. Antimicrob Agents Chemother. 2009;53(7):2887–91.
Koye DN, Magliano DJ, Nelson RG, Pavkov ME. The Global Epidemiology of Diabetes and Kidney Disease. Adv Chronic Kidney Dis. Elsevier Ltd; 2018;25(2):121–132.
Hsu CY, Ordoñez JD, Chertow GM, Fan D, McCulloch CE, Go AS. The risk of acute renal failure in patients with chronic kidney disease. Kidney Int. 2008 Jul;74(1):101–7.
Kheterpal S, Tremper KK, Heung M, Rosenberg AL, Englesbe M, Shanks AM, et al. Development and Validation of an Acute Kidney Injury Risk Index for Patients Undergoing General Surgery. Anesthesiology. 2009;110(3):505–15.
Kohno S, Imamura Y, Shindo Y, Seki M, Ishida T, Teramoto S, et al. Clinical practice guidelines for nursing- and healthcare-associated pneumonia (NHCAP) [Complete translation]. Respir Investig. Elsevier; 2013;51(2):103–126.
Yamamoto S, Ishikawa K, Hayami H, Nakamura T, Miyairi I, Hoshino T, et al. JAID/JSC Guidelines for Clinical Management of Infectious Disease 2015 − Urinary tract infection/male genital infection. J Infect Chemother. 2017;23(11):733–51.